CHF93.89
1.61% today
SIX Swiss Exchange, Apr 02, 05:31 pm CET
ISIN
CH1335392721
Symbol
GALD
Sector
Industry

Galderma Stock price

CHF93.89
-18.77 16.66% 1M
+17.83 23.44% 6M
-6.75 6.71% YTD
+29.76 46.41% 1Y
+40.89 77.15% 3Y
+40.89 77.15% 5Y
+40.89 77.15% 10Y
SIX Swiss Exchange, Closing price Wed, Apr 02 2025
-1.54 1.61%
ISIN
CH1335392721
Symbol
GALD
Sector
Industry

Key metrics

Market capitalization CHF22.66b
Enterprise Value CHF24.74b
P/E (TTM) P/E ratio 112.07
EV/FCF (TTM) EV/FCF 78.82
EV/Sales (TTM) EV/Sales 6.37
P/S ratio (TTM) P/S ratio 5.83
P/B ratio (TTM) P/B ratio 3.21
Dividend yield 0.16%
Last dividend (FY25) CHF0.15
Revenue growth (TTM) Revenue growth 5.91%
Revenue (TTM) Revenue CHF3.88b
EBIT (operating result TTM) EBIT CHF570.35m
Free Cash Flow (TTM) Free Cash Flow CHF313.88m
EPS (TTM) EPS CHF0.85
P/E forward 61.71
P/S forward 5.28
EV/Sales forward 5.77
Show more

Is Galderma a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Galderma Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Galderma forecast:

9x Buy
75%
3x Hold
25%

Analyst Opinions

12 Analysts have issued a Galderma forecast:

Buy
75%
Hold
25%

Financial data from Galderma

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
3,884 3,884
6% 6%
100%
- Direct Costs 1,193 1,193
8% 8%
31%
2,691 2,691
5% 5%
69%
- Selling and Administrative Expenses 1,633 1,633
6% 6%
42%
- Research and Development Expense 229 229
11% 11%
6%
828 828
8% 8%
21%
- Depreciation and Amortization 258 258
4% 4%
7%
EBIT (Operating Income) EBIT 570 570
10% 10%
15%
Net Profit 202 202
500% 500%
5%

In millions CHF.

Don't miss a Thing! We will send you all news about Galderma directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Galderma Group AG engages in the provision of science-based premium dermatology solutions. The firm is also involved in delivering a synergistic portfolio of flagship brands spanning the full spectrum of the fast-growing self-care dermatology market. The company was founded in 1981 and is headquartered in Zug, Switzerland.

Head office Switzerland
CEO Flemming Ørnskov
Website www.galderma.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today